Description: 2021 Life Meeting - Session 8B: Proxy Discrimination in Life Insurance 9.1.21 Recording

Description: Employers, health plans, stop-loss insurers and reinsurers are all affected by the high cost of treating cancer. In recent years, cutting-edge pharmaceuticals, bone marrow transplants and CAR-T cell therapies have driven very high cost trends for cancer, with more emerging therapies on the horizon. In this session, we will review these new treatments, showcase models that aid in understanding the range of likely financial effects of the current, expanded, and likely-to-be approved indications for cell therapies that will treat certain patients affected by lymphoma, leukemia, and multiple myeloma. This session will explain important considerations for modeling Medicare, Medicaid versus commercial populations, key risk concerns caused by the size of enrollee pools, and important differences between the various therapies that affect modeling. We will also discuss averted cost, health outcomes, pricing levels, and risks caused by provider billing practices.

Description: For actuaries interested in term life insurance, add this webcast to your calendar. Our panel of experts will discuss term life insurance from the following perspectives: Pricing Product development Reserving Risk management They will also discuss exploring data visualizations using Tableau.

Description: This paper provides actuaries with background and scientific knowledge to understand global climate change and climate model projections for the 21st century.

Description: This is the first in a series of calls for essays on the impact of AI on mortality and longevity. For this call for essays, we are interested in the impact of AI on mortality and longevity modeling, forecasting and prediction.

Description: This article discusses value at risk, VaR, and VaR modeling of the bank's portfolios that would recognize diversity and hedging. This article also covers the differences between classical VaR and the longer horizons required by the insurance industry and the feasibility of extending VaR to the insurance industry.

Description: In this discussion, Peter Bishop provides an update of the topics and conclusions of the July meeting of the World Future Society and expands upon the issues most relevant to actuaries, including the status of current futurism research and the significance of emerging knowledge. From Record of Society of Actuaries, Vol. 30, No. 3.

Description: Read the April 2020 issue of The Modeling Platform, published by the Modeling Section. Newsletters provide practical information for the working actuary, articles on trends that impact sections and news about section activities.

Description: Excel file model of the Impact of Social Distancing on the Spread of a Communicable Virus.

Description: The IFRS 17 implementation deadline is near and companies have decisions to make. While many decisions pertain to specific IFRS 17 requirements, others are more strategic in nature. This session will explore key considerations and decisions faced by stakeholders as they finalize their implementation work and determine ongoing best practices in light of this new standard.